Tracking a new treatment's power to protect joints in hemophilia patients

NCT ID NCT06940830

Recruiting now Disease control Sponsor: Swedish Orphan Biovitrum Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how well a preventive treatment called efanesoctocog alfa protects joint health over time in people with hemophilia A. It will follow about 250 people already prescribed this medication in real-world settings for 2-3 years, tracking their joint bleeds and overall health. The goal is to see if this long-term preventive treatment helps reduce joint damage and improve quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Sobi Investigational Site
RECRUITING

Zagreb, Croatia
Sobi Investigational Site
RECRUITING

Brno, Czechia
Sobi Investigational Site
RECRUITING

Ostrava, Czechia
Sobi Investigational Site
RECRUITING

Prague, Czechia
Sobi Investigational Site
RECRUITING

Bordeaux, France
Sobi Investigational Site
RECRUITING

Marseille, France
Sobi Investigational Site
RECRUITING

Montpellier, France
Sobi Investigational Site
RECRUITING

Nantes, France
Sobi Investigational Site
RECRUITING

Paris, France
Sobi Investigational Site
RECRUITING

Rennes, France
Sobi Investigational Site
RECRUITING

Rouen, France
Sobi Investigational Site
RECRUITING

Berlin, Germany
Sobi Investigational Site
RECRUITING

Bonn, Germany
Sobi Investigational Site
RECRUITING

Frankfurt am Main, Germany
Sobi Investigational Site
RECRUITING

Hamburg, Germany
Sobi Investigational Site
RECRUITING

Munich, Germany
Sobi Investigational Site
RECRUITING

Dublin, Ireland
Sobi Investigational Site
RECRUITING

Turin, Italy
Sobi Investigational Site
RECRUITING

A Coruña, Spain
Sobi Investigational Site
RECRUITING

Barcelona, Spain
Sobi Investigational Site
RECRUITING

Málaga, Spain
Sobi Investigational Site
RECRUITING

Palma de Mallorca, Spain
Sobi Investigational Site
RECRUITING

Zaragoza, Spain
Sobi Investigational Site
RECRUITING

Birmingham, United Kingdom
Sobi Investigational Site
RECRUITING

Cardiff, United Kingdom
Sobi Investigational Site
RECRUITING

London, United Kingdom
Sobi Investigational Site
RECRUITING

Manchester, United Kingdom

Conditions

Explore the condition pages connected to this study.

HEMOPHILIA A